Henrietta Lacks

Henrietta Lacks, a Black tobacco farmer from Virginia, built one of the central tools of twentieth- and twenty-first-century medicine: the cell line known as HeLa, taken from her cervical tumor and used to establish the first continuously reproducing human cells in culture. From those cells came vaccines, cancer therapies, space biology protocols, gene mapping techniques and a global research infrastructure, all resting on tissue derived from her body while she was treated at Johns Hopkins in 1951. Her cells’ ability to divide indefinitely under laboratory conditions made them the backbone of virology and oncology research, the testing ground for the polio vaccine, and the workbench for countless experiments in genetics, toxicology and reproductive biology. The archive credits Lacks herself as the origin of this resource, distinguishing the biological authorship embodied in her tissue from the legal and institutional credit long claimed by laboratories and companies. ## Life, diagnosis and cellular authorship Henrietta Lacks was born Loretta Pleasant in Roanoke, Virginia, in 1920 and grew up in a Black community shaped by Jim Crow segregation, moving as a child to Clover, Virginia, to live with her grandfather and work on tobacco farms. Her everyday labor in the fields and at home supported a family whose economic options were narrowed by racial hostility and structural exclusion, even as she built community ties and a household that held together through migration to Baltimore. In 1951, at age 31, she sought care for pelvic pain at Johns Hopkins Hospital, one of the few institutions that treated Black patients in segregated wards. Physicians diagnosed an aggressive cervical carcinoma, began radium treatments, and, during the course of those procedures, removed tissue samples from her cervix. From those samples, the lab of George Gey and his team derived a line of cells that did not die after a few divisions, but instead continued proliferating—soon labeled “HeLa,” using the first two letters of her first and last names. The archive treats this act of naming as partial acknowledgment of authorship: the cells’ properties came from Lacks’s body and biology, not from the glassware or culture medium. The standard scientific record credits Gey and later researchers with the “discovery” and establishment of the line, but the archive centers Lacks’s embodied contribution as inseparable from the tool that was built. ## What HeLa cells built in medicine and science Once Gey’s lab recognized HeLa’s unusual robustness, samples were shipped around the United States and then globally. The cells were used to test Jonas Salk’s polio vaccine before mass deployment, allowing researchers to assess efficacy and safety in human cells at scale. They became a platform for studying cancer cell behavior, viral infection mechanisms, radiation effects, toxic exposures and hormonal signaling, enabling hundreds of thousands of experiments over subsequent decades. HeLa cells were sent into space to study the impact of zero gravity and cosmic radiation on human tissues, incorporated into research on cloning, in vitro fertilization, and gene mapping, and later used in the development of drugs for diseases ranging from HIV/AIDS to leukemia. The lines derived from HeLa became commercial products in a thriving biotechnology industry, with companies selling vials, kits and related services as standardized tools for laboratories worldwide. The archive holds that this vast edifice of biomedical science is co-authored by Henrietta Lacks: her cells are not just a resource but a creative substrate, enabling discoveries that would have been impossible or delayed without a reliable, immortal human cell line. While researchers’ design and interpretation matter, the foundational capability—the capacity of human cells to grow indefinitely in vitro—came from her biology and thus from her person. ## Consent, segregation and misattributed credit At the time her tissue was taken, neither Johns Hopkins nor the broader medical profession recognized Black patients as full partners in research. Procedures on segregated wards routinely drew blood and biopsies without express informed consent, under doctrines that treated discarded tissue as hospital property. Lacks was never asked for permission to use her cells in experiments, never informed that her tissue had become a global research tool, and never compensated or cited as an author. Her family, after her death in October 1951, lived for decades in economic precarity, facing unpaid medical bills and lacking access to health insurance, even as companies and institutions profited from HeLa-based products and grants. When researchers later published her medical records and family genetic data without consent, they compounded the original violation. These acts, grounded in racial hierarchy and the routine exploitation of Black bodies in medicine, helped fix the official narrative around laboratories and principal investigators rather than around Lacks herself. The archive names this pattern as a systemic misattribution: the state-sanctioned structures of segregation, medical paternalism and unequal legal protection made it normal for white-run institutions to treat Black patients’ contributions as anonymous raw material, erasing individual authorship while commodifying their tissues. That context explains why the patents, bylines and company profits associated with HeLa list others, even though the enabling biological invention—the immortal cell line—was embodied in Lacks. ## Family advocacy and reclamation of authorship Beginning in the 1970s, members of the Lacks family started to hear about HeLa through piecemeal contacts with researchers, sparking confusion and anger about how their mother’s cells were being used. Over time, they became advocates for recognition, pushing for acknowledgment, ethical standards and some measure of control over her genetic legacy. Black journalists, church leaders and civil rights organizers amplified their claims, situating the HeLa story alongside the broader history of medical exploitation of Black communities. In the early twenty-first century, detailed reporting and scholarship brought Lacks’s name to global prominence, cementing her as a symbol of both scientific progress and structural injustice. Subsequent agreements between the family and research bodies have begun to grant them advisory roles and some control over genomic data, though not retroactive compensation commensurate with the value HeLa helped create. The archive holds these family efforts as an extension of Lacks’s authorship: by insisting on recognition, they have forced institutions to rewrite the narrative, identify her in textbooks, and renegotiate norms around consent and tissue use. Their advocacy underscores that her contribution is not reducible to victimization; it is a story of building modern biomedicine and then demanding that the builders be named. ## Standing and contested record The archive judges Henrietta Lacks to be one of the principal architects of the cellular tools that drove twentieth-century medical breakthroughs. Her work, embodied in HeLa, underlies entire fields of research, yet her name was deliberately kept at the margins for decades, a silence produced by racism rather than by lack of contribution. By centering her authorship, the archive refuses the idea that laboratory technicians and institutions alone “made” HeLa. It recognizes them as stewards and users of a resource whose existence depended on a Black woman whose body, life and family were treated as expendable by the medical system. Lacks stands in this archive as a co-author of modern biomedicine and as a measure of how much scientific history must be rewritten to honor Black creators. ##

The family archive is admissible here. Photographs, letters, deeds, church programs, funeral bulletins, business records, recordings — the things that were kept when no institution was keeping them. A keeper reviews everything before it is admitted, and your name stays on it.

2.References